CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. San Diego, California San Diego Marriott Marquis & Marina October 3 5, Participating Faculty

Transcription

1 CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE San Diego, California San Diego Marriott Marquis & Marina October 3 5, 2014 Participating Faculty Hector O. Ventura, MD, FACC Section Head, Cardiomyopathy and Heart Transplant Ochsner Clinic Foundation New Orleans, Louisiana Professor, Cardiology The University of Queensland School of Medicine Ochsner Clinical School Brisbane, Australia Michael J. Waxman, MD, MBA Medical Director Medical Surgical Intensive Care Unit Research Medical Center Kansas City Pulmonology Practice Clinical Associate Professor UMKC Clinical Assistant Professor KUMC Adjunct Professor Rockhurst University Andrew Weintraub, MD, FACC Medical Director Valvular and Structural Heart Health Center Associate Director Cardiac Catheterization Laboratory Director Coronary Care Unit Tufts Medical Center Boston, Massachusetts

2 Hector O. Ventura, MD, FACC Section Head, Cardiomyopathy and Heart Transplant Ochsner Clinic Foundation New Orleans, Louisiana Professor, Cardiology The University of Queensland School of Medicine Ochsner Clinical School Brisbane, Australia Dr. Ventura received his medical degree from the National University of Buenos Aires in Argentina. His Internship was at the Ochsner Medical Institutions where he also became a Fellow in Cardiovascular Diseases. He became a Fellow in Heart Failure/Heart Transplantation from Loyola University. Dr. Ventura is board certified in cardiology and has a wide range of special expertise including the history of medicine. He has written numerous articles for scientific medical publications and serves on several editorial boards of medical journals and is the Associate Editor for Congestive Heart Failure. He is a staff member, Cardiology Section, Director, Cardiovascular Disease Training Program & Education, Chairman, Graduate Medical Education, and the Director, Heart Failure Cardiomyopathy Center at Ochsner Heart and Vascular Institute. Dr. Ventura is an Associate Professor of Medicine at the Louisiana State University School of Medicine and a Professor of Medicine at Tulane University School of Medicine.

3 Michael J. Waxman, MD, MBA Medical Director Medical Surgical Intensive Care Unit Research Medical Center Kansas City Pulmonology Practice Clinical Associate Professor UMKC Clinical Assistant Professor KUMC Adjunct Professor Rockhurst University Michael J. Waxman, M.D. is the Medical Director of the Medical-Surgical ICU at Research Medical Center. As a pulmonologist and intensivist, he is a member of The Kansas City Pulmonology Practice. He is also the Medical Director of Kindred Hospital, Kansas City. Dr. Waxman is a 1976 graduate of The University of Kansas School of Medicine, where he completed an internal medicine residency and fellowship training in pulmonary and critical care medicine. He is board certified in internal medicine, pulmonary medicine and critical care medicine. One of Dr Waxman s special interest has included pulmonary interventional therapy, such as laser resection and stent placement. Dr. Waxman is heavily invested in teaching. He lectures on topics of pulmonary and critical care. He has a 27 year association with The Kansas City Southwest Clinical Society, the oldest, purely scientific society west of the Mississippi. He is a past President of the Society as well as twice having served as Director of Clinics. For the past 13 years, he has served as the Society s program director of Current Management in Critical Care Medicine, a critical care meeting which convenes each spring in the Kansas City area. Dr. Waxman is course director of Fundamental Critical Care Support, a proprietary course in critical care education developed by the Society of Critical Care

4 Medicine to teach critical care to the non-intensivist. He holds the position of Clinical Assistant Professor, Medicine (Respiratory and Critical Care), University of Missouri- Kansas City and Clinical Assistant Professor in the Department of Internal Medicine, School of Medicine, University of Kansas Medical Center. He is a fellow of the American College of Physicians and also of the American College of Chest Physicians. For 27 years, Dr. Waxman has worked with the Missouri peer review organization evaluating issues of quality care and utilization review. He is a diplomate of the American Board of Quality Assurance and Utilization Review Physicians. Dr. Waxman just graduated in May, 2012 from the Executive Fellows MBA program at Rockhurst University in Kansas City. His future plans with this education are to work in education and process management to improve the health care delivery system.

5 Andrew Weintraub, MD, FACC Medical Director Valvular and Structural Heart Health Center Associate Director Cardiac Catheterization Laboratory Director Coronary Care Unit Tufts Medical Center Boston, Massachusetts Dr. Weintraub received his undergraduate degree from Hobart College in Geneva, New York and his medical degree from Georgetown University School of Medicine in Washington, DC. He completed an internship and residency in Internal Medicine and a fellowship in Cardiovascular Medicine at Tufts New England Medical Center in Boston. Dr. Weintraub is board certified in Internal Medicine and Cardiovascular Medicine. He is a Fellow in the American College of Cardiology and a member of the Massachusetts Medical Society. Dr. Weintraub has been recognized in Best Doctors in America several times and Best Doctor-Boston Magazine. He has published numerous papers and abstracts as well as speaking at many invited lectures and conferences. His research interests are in the application of invasive devices in measurement of vascular anatomy and interaction of patient specific risk factors on outcomes following PCTI.

6 Friday, October 3rd: 7:30 am - 8:00 am Registration and Hot Breakfast 8:00 am - 9:00 am Michael J. Waxman, MD, MBA Asthma The medical impact of asthma; fundamental role of inflammation, with possible scarring and irreversible loss of lung function; practical points of diagnosis; goal setting management based on levels of severity; risk factors for mortality and treatment in the acute setting; management options for the difficult to control asthmatic patient 9:00 am 9:50 am Michael J. Waxman, MD, MBA Controversies in the Treatment of Common Respiratory Infections Acute and chronic bronchitis; pneumonia (community versus hospital-acquired); role of the Pneumonia Severity Index score in determining indication for hospitalization; costeffective use of antibiotics; clinical significance of drug resistance; guidelines for management 9:50 am - 10:00 am Coffee Break 10:00 am 10:50 am Andrew Weintraub, MD, FACC Work-up of Patients with Suspected CAD: Which Tests for Which Patients Risk factor evaluation; symptom evaluation; test selection including stress ECG, echo, nuclear and newer imaging modalities; role of CRP and EBCT; evaluating women who needs coronary angiography? 10:50 am 11:40 am Andrew Weintraub, MD, FACC Medical Management of Patients with Chronic Coronary Disease Pharmacology of the treatment of angina, antiplatelet therapy, the use of noninvasive testing in following patients with known CAD, secondary prevention 11:40 am - 12:40 pm Andrew Weintraub, MD, FACC Case Presentations 12:40 pm Session Adjourns

7 Saturday, October 4th: 7:30 am - 8:00 am Hot Breakfast 8:00 am 8:50 am Andrew Weintraub, MD, FACC Primary and Secondary Prevention of CAD AHA/ACC Updated Lipid Guidelines update; what about HDL-C?; metabolic syndrome; role of exercise and cardiac rehabilitation 8:50 am 9:40 am Hector O. Ventura, MD, FACC Hypertension Update JNC-8 update; goals of treatment; thiazides for all?; special populations diabetics, the elderly, renal failure 9:40 am 9:50 am Coffee Break 9:50 am 10:50 am Hector O. Ventura, MD, FACC Congestive Heart Failure Etiologies and stages of heart failure; clinical evaluation; LV systolic vs. diastolic dysfunction; treatment including ACE inhibitors, ARBs, beta blockers; ACC/AHA Heart Failure Guideline Update 10:50 am 11:40 am Michael J. Waxman, MD, MBA Everything You Need to Know About COPD Definition; pathophysiology; early detection and intervention; risk reduction; management update including new modalities (including lung volume reduction surgery) and the role of inhaled corticosteroids and domiciliary oxygen 11:40 am - 12:40 pm Michael J. Waxman, MD, MBA Case Presentations 12:40 pm Session Adjourns

8 Sunday, October 5th: 7:30 am - 8:00 am Continental Breakfast 8:00 am - 9:00 am Hector O. Ventura, MD, FACC Arrhythmia Management for the Primary Care Physician Types and symptoms of arrhythmias; approach to the patient; when to refer, when to admit; atrial fibrillation; ventricular arrhythmias when are they serious? 9:00 am - 10:00 am Hector O. Ventura, MD, FACC Case Presentations 10:00 am Conference Adjourns Target Audience This program is targeted to office-based primary care providers and other health professionals with updates in primary care medicine Learning Objectives Upon completion of this program, participants should be better able to: Describe current diagnostic approaches to hypertension, congestive heart failure, arrhythmias, CAD, and chronic coronary disease Implement treatment strategies reflective of current evidence based medicine for hypertension, congestive heart failure, arrhythmias, CAD, and chronic coronary disease Identify the pathophysiology and diagnostic approach of asthma, COPD and common respiratory infections Design treatment strategies reflective of current evidence based medicine for asthma, COPD and common respiratory infections Nursing Purpose Statement To provide updates in primary care medicine to office based providers

9 Disclosure of Conflicts of Interest Medical Education Resources insures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a CME activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality CME activities that promote improvements or quality in health care and not the business interest of a commercial interest. The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this CME activity: Name of Faculty Reported Financial Relationship Hector O. Ventura, MD Speakers Bureau: Otsuka, Actelion Michael J. Waxman, MD, MBA No financial relationships to disclose Andrew Weintraub, MD, FACC Grants/Research Support: Gilead Pharmaceuticals, Medtronic, Inc. The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this CME activity: Name of Content Manager Reported Financial Relationship MER content managers No financial relationships to disclose MER nurse reviewer No financial relationships to disclose Disclaimer The content, views and opinions presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. MER s ANCC accreditation status does not imply endorsement by MER or ANCC of any commercial products displayed in conjunction with this activity. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient s conditions and possible contraindications on dangers in use, review of any applicable manufacturer s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

10 Accreditation Physician Accreditation Medical Education Resources is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Credit Designation Medical Education Resources designates this live activity for a maximum of 11 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity. American Academy of Family Physicians This Live activity, Cardio/Pulmonary Medicine for Primary Care, with a beginning date of October 3, 2014 has been reviewed and is acceptable for up to 11 Prescribed credits by the American Academy of Family Physicians. Physicians should only claim the credit commensurate with the extent of their participation in the activity. American Osteopathic Association These programs are approved for 11 hours in Category 2-A by the American Osteopathic Association. American College of Emergency Physicians This program is approved by the American College of Emergency Physicians for a maximum of 11 hours of ACEP Category I credit. Canadian Physicians The College of Family Physicians of Canada (CFPC) has a reciprocal credit agreement with the American Academy of Family Physicians (AAFP) for activities which offer Prescribed credit. CFPC members who complete these conferences may claim the equivalent number of Mainpro- M1 credits. American Academy of Physician Assistants AAPA accepts certificates of participation for educational activities certified for Category I credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 Credit(s) TM from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 11 hours of Category I credit for completing this program. Nursing Accreditation Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center s Commission on Accreditation. This CE activity provides 11 contact hours of continuing nursing education. Provider approved by the California Board of Registered Nursing, Provider Number 12299, for 11 contact hours.

11 Pharmacy Accreditation Medical Education Resources (MER) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MER designates this continuing education activity for 11 contact hours (1.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Program Number: L01-P Participants will be required to sign in at the start of the program and/or complete a program evaluation form. Certificates of credit will be provided at the conclusion of the activity. This activity is certified as Knowledge-based CPE.